Kairos Venture Investments, Llc
Venture capitalBeverly Hills · Pre-Seed–Series A
Investment thesis
Kairos Ventures backs world-class scientists and engineers at the earliest stages of company formation to commercialize scientific discoveries into viable businesses. The firm invests between $150,000 and $20 million, works closely with researchers to translate knowledge and ideas into scalable ventures, and provides operational support across legal, finance, marketing, business development, and HR. The firm prioritizes preserving founder ownership and believes that top-tier scientists paired with supportive investors can generate significant global impact and shareholder returns.
Source: firm website, verified Jul 21, 2026.
Investments · 32 tracked
founders shown can be your intro pathUses medicinal chemistry technology and biomarker-driven assays to accelerate pre-clinical drug discovery and clinical development.
Develops radiation detection solutions for medical imaging, nuclear energy, and non-proliferation applications.
Clinical-stage therapeutics company focusing on high-impact cancers and inflammatory diseases.
Develops patented technologies for metal manufacturing and material innovation that eliminate traditional machining processes.
Clinical-stage company developing non-invasive treatment for kidney stones affecting millions annually.
Biopharmaceutical company harnessing the gut microbiome-central nervous system connection to develop novel therapeutics.
Provides emotion recognition and behavioral analytics technology that analyzes conversations to extract emotions and behavioral patterns.
Cloud-based, AI-enabled healthcare data analytics platform that transforms data into actionable insights with advisory services.
Biopharmaceutical company using molecular biology to produce recombinant derivatives of botulinum neurotoxin for customized applications.
SaaS health tech platform using advanced data analytics to drive disease-specific, coordinated care pathways with streamlined workflows.
Develops next-generation drug delivery systems to improve clinical and commercial value of new and existing drugs.
Clinical-stage company that developed the first synthetic polymer aortic and mitral heart valves.
Developed the first true wireless power transmission technology enabling previously impossible applications.
Immunotherapy startup delivering nematode-derived molecules to treat autoimmune disorders.
Leading provider of advanced femtosecond lasers to top universities and research institutions worldwide.
Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.
Uses proprietary AI platform to accelerate materials discovery by screening millions of compounds and deciphering the materials genome.
Develops software enabling seamless convergence of computer memory and storage using non-volatile RAM memory.
Developing small, cost-effective infrared spectrometer for rapid chemical mixture analysis.
Multi-award-winning 5G mmWave chips offering breakthrough range and efficiency; acquired by Sivers Semiconductors in January 2022.
Provides nanotech coatings offering anti-fogging capabilities in consumer wearables and improved electronic display brightness.
Development-stage biopharmaceutical company focused on therapeutics for neurodegenerative disorders including Alzheimer's and Parkinson's.
Pioneering large-scale nano-architected materials production for diverse applications.
Early-stage ophthalmology company focused on treating ischemic eye diseases like age-related macular degeneration and diabetic retinopathy.
Develops integrated microfluidic technologies for dosing control in handheld vape products using patented breakthrough technologies.
World's first mass producer of insect pheromones used as an alternative to insecticides for crop protection.
Develops VTOL aircraft with superior cargo efficiency through folding/unfolding wing design transitioning between rotor and fixed wing modes.
Developing rapid, point-of-care diagnostic tool with single-molecule precision for identifying diverse analytes.
Develops technologies improving combustion and reacting flow processes for energy, aerospace, and defense applications.
Develops nanosecond pulsed power systems that increase fuel efficiency and reduce emissions significantly.
Platform technology creating a new preclinical drug development pipeline using lab-grown human biology models.
Revolutionizing the razor blade industry with proprietary Bulk Metal Glass technology in partnership with Kairos portfolio company Amorphology.
Frequently asked questions
- What stage does Kairos Venture Investments, Llc invest at?
- Kairos Venture Investments, Llc invests at the Pre-Seed, Seed, Series A stages.
- What is Kairos Venture Investments, Llc's typical check size?
- Kairos Venture Investments, Llc typically writes checks of $150K – $20M.
- What sectors does Kairos Venture Investments, Llc focus on?
- Kairos Venture Investments, Llc focuses on Deep Tech, Sector Agnostic.
- Where is Kairos Venture Investments, Llc located?
- Kairos Venture Investments, Llc is headquartered in Beverly Hills, US.
- Does Kairos Venture Investments, Llc lead rounds?
- Yes, Kairos Venture Investments, Llc leads investment rounds.
Similar investors
8VC is a technology investment firm focused on building and investing in ambitious companies across life sciences, healthcare, manufacturing, enterprise, logistics, and defense sectors, with particular emphasis on operational intelligence and data-driven decision-making.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Tennr streamlines patient flow in healthcare by automating referral management, insurance verification, clinical context aggregation, and appointment scheduling. The platform processes referrals and intake documentation for approximately 10% of Americans annually.
Hyderabad Angels is a collective of experienced entrepreneurs, industrialists, and family offices founded in 2010 that provides mentorship, capital, and network access to early-stage founders. The organization invests in seed and pre-seed companies across sector-agnostic technology, healthcare, consumer, and other emerging sectors.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.